MEDIGEN, INC.
8Patents
8Active
8Granted
46Portfolio score
Filing activity: Jul 17, 2009 → Jan 12, 2023 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9101572B2 | Infectious DNA vaccines against chikungunya virus | Chemistry; Metallurgy | 12 | Active |
| US8691563B2 | IDNA vaccines and methods for using the same | Emerging Cross-Sectional Technologies | 11 | Active |
| US9694065B2 | Infectious DNA vaccines against chikungunya virus | Emerging Cross-Sectional Technologies | 1 | Active |
| US11576965B2 | Recombinant bovine immunodeficiency virus gag virus-like particles containing influenza immunogens | Emerging Cross-Sectional Technologies | 1 | Active |
| US9968672B2 | IDNA vaccines and methods for using the same | Emerging Cross-Sectional Technologies | 1 | Active |
| US10653769B2 | iDNA vaccines and methods for using the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US11058759B2 | Vaccines against infectious diseases caused by positive stranded RNA viruses | Emerging Cross-Sectional Technologies | 0 | Active |
| US12303560B2 | Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.